InsidersTradesSigma
Discover the detailed record of transactions filed by Beckman Daniella, Director. Officer active across 1 companies, notably Blueprint Medicines Corp. In total, 2 filings have been recorded. The latest transaction was filed on 21 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Daniella Beckman serves as a Director at Blueprint Medicines Corp. She participates in overseeing the company's activities and making strategic decisions. Her experience in the pharmaceutical sector allows her to provide valuable insights to the board. She plays a key role in corporate governance and performance evaluation.